These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7836072)

  • 1. HLA-B35-subtype mismatches in ABDR serologically matched unrelated donor-recipient pairs.
    Rufer N; Breur-Vriesendorp B; Tiercy JM; Gauchat-Feiss D; Shi X; Slavcev A; Lardy N; Chapuis B; Gratwohl A; Speiser D
    Hum Immunol; 1994 Sep; 41(1):96-101. PubMed ID: 7836072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histoincompatibilities in ABDR-matched unrelated donor recipient combinations.
    Rufer N; Tiercy JM; Breur-Vriesendorp B; Gauchat-Feiss D; Shi X; Slavcev A; Lardy N; Speiser D; Gratwohl A; Chapuis B
    Bone Marrow Transplant; 1995 Nov; 16(5):641-6. PubMed ID: 8547860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular characterization of HLA-C incompatibilities in HLA-ABDR-matched unrelated bone marrow donor-recipient pairs. Sequence of two new Cw alleles (Cw*02023 and Cw*0707) and recognition by cytotoxic T lymphocytes.
    Grundschober C; Rufer N; Sanchez-Mazas A; Madrigal A; Jeannet M; Roosnek E; Tiercy JM
    Tissue Antigens; 1997 Jun; 49(6):612-23. PubMed ID: 9234483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-resolution histocompatibility testing of a group of sixteen B44-positive, ABDR serologically matched unrelated donor-recipient pairs. Analysis of serologically undisclosed incompatibilities by cellular techniques, isoelectrofocusing, and HLA oligotyping.
    Rufer N; Breur-Vriesendorp BS; Tiercy JM; Slavcev AS; Lardy NM; Francis P; Kressig R; Speiser DE; Helg C; Chapuis B
    Hum Immunol; 1993 Nov; 38(3):235-9. PubMed ID: 8106284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneity of HLA-B35. Oligotyping and direct sequencing for B35 subtypes reveals a high mismatching rate in B35 serologically compatible kidney and bone marrow donor/recipient pairs.
    Gauchat-Feiss D; Rufer N; Speiser D; Jeannet M; Roosnek E; Tiercy JM
    Transplantation; 1995 Oct; 60(8):869-73. PubMed ID: 7482749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pretransplant cytotoxic donor T-cell activity specific to patient HLA class I antigens correlating with mortality after unrelated BMT.
    Speiser DE; Löliger CC; Siren MK; Jeannet M
    Br J Haematol; 1996 Jun; 93(4):935-9. PubMed ID: 8703829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mismatches for two major and one minor histocompatibility antigen correlate with a patient's rejection of a bone marrow graft from a serologically HLA-identical sibling.
    Lienert-Weidenbach K; Valiante NM; Brown C; White C; Johnston-Dow L; McGinnis M; Krausa P; Lakes DM; Wolf JL; Blume KG; Parham P
    Biol Blood Marrow Transplant; 1997 Nov; 3(5):255-60. PubMed ID: 9450920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimates of cytotoxic T-lymphocyte precursor frequencies against HLA class I antigens in responder-stimulator pairs with a negative mixed lymphocyte culture reaction.
    Slavcev AS; Breur-Vriesendorp BS; Ivanyi P
    Hum Immunol; 1995 Oct; 44(2):97-102. PubMed ID: 8847234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presentation of human minor histocompatibility antigens by HLA-B35 and HLA-B38 molecules.
    Yamamoto J; Kariyone A; Akiyama N; Kano K; Takiguchi M
    Proc Natl Acad Sci U S A; 1990 Apr; 87(7):2583-7. PubMed ID: 2157206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of HLA-DP mismatches on primary MLR responses in unrelated HLA-A, B, DR, DQ, Dw identical pairs in allogeneic bone marrow transplantation.
    Cesbron A; Moreau P; Milpied N; Muller JY; Harousseau JL; Bignon JD
    Bone Marrow Transplant; 1990 Nov; 6(5):337-40. PubMed ID: 1981326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of pretransplant CTL activity in "perfectly matched" unrelated bone marrow donor/recipient combinations.
    Rufer N; Tiercy JM; Speiser D; Helg C; Gratwohl A; Chapuis B; Jeannet M; Roosnek E
    Bone Marrow Transplant; 1993; 11 Suppl 1():20-3. PubMed ID: 8448539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphism of human minor histocompatibility antigens: T cell recognition of human minor histocompatibility peptides presented by HLA-B35 subtype molecules.
    Beck Y; Satz L; Takamiya Y; Nakayama S; Ling L; Ishikawa Y; Nagao T; Uchida H; Tokunaga K; Müller C
    J Exp Med; 1995 Jun; 181(6):2037-48. PubMed ID: 7759996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA-DRB1 matched kidneys are preferentially HLA-A and -B compatible and survive longer.
    Speiser DE; Jeannet M; Goumaz C; Tiercy JM
    Transpl Immunol; 1994 Dec; 2(4):350-2. PubMed ID: 7704545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discrimination of HLA-B5 crossreactive group antigens by human allospecific CTL clones.
    Matsumoto K; Yamamoto J; Hiraiwa M; Kano K; Takiguchi M
    Transplantation; 1990 Jun; 49(6):1164-7. PubMed ID: 2360256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-reactive memory T cells for Epstein-Barr virus augment the alloresponse to common human leukocyte antigens: degenerate recognition of major histocompatibility complex-bound peptide by T cells and its role in alloreactivity.
    Burrows SR; Silins SL; Khanna R; Burrows JM; Rischmueller M; McCluskey J; Moss DJ
    Eur J Immunol; 1997 Jul; 27(7):1726-36. PubMed ID: 9247584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA matching effect on five-year graft survival and half-life in the cyclosporine era.
    Mitsuishi Y; Terasaki PI
    Kidney Int Suppl; 1992 Oct; 38():S172-5. PubMed ID: 1405371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of pretransplant donor anti-recipient cytotoxic and helper T lymphocyte responses as correlates of acute graft-vs.-host disease and survival after unrelated marrow transplantation.
    Pei J; Martin PJ; Longton G; Masewicz S; Mickelson E; Petersdorf E; Anasetti C; Hansen J
    Biol Blood Marrow Transplant; 1997 Aug; 3(3):142-9. PubMed ID: 9310191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA-A, B, C, DRB1, DQB1 matching heterogeneity in 'favourably matched' kidney recipients.
    Rees MT; Darke C
    Transpl Immunol; 2003; 12(1):73-8. PubMed ID: 14551034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytotoxic T cell reactivity and HLA-B35 binding of the variant Plasmodium falciparum circumsporozoite protein CD8+ CTL epitope in naturally exposed Kenyan adults.
    Udhayakumar V; Ongecha JM; Shi YP; Aidoo M; Orago AS; Oloo AJ; Hawley WA; Nahlen BL; Hoffman SL; Weiss WR; Lal AA
    Eur J Immunol; 1997 Aug; 27(8):1952-7. PubMed ID: 9295031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oligotyping of HLA-A2, -A3, and -B44 subtypes. Detection of subtype incompatibilities between patients and their serologically matched unrelated bone marrow donors.
    Tiercy JM; Djavad N; Rufer N; Speiser DE; Jeannet M; Roosnek E
    Hum Immunol; 1994 Nov; 41(3):207-15. PubMed ID: 7868376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.